选择性胆碱酯酶抑制剂──加兰他敏

[1] Thomsen T et al. Life Sciences . 1990

[2] Bickel U et al. Neuropharmacology . 1991

[3] Pharmacology[C]. 2002年中日毒理学和药理学联合研讨会,2002

[4] Sweeney J E et al. Psychopharmacology . 1990

[5] Sweeney J E et al. Pharmacol Biochem Behav . 1989

[6] Thomsen T et al. European Journal of Clinical Pharmacology .

[7] Thomsen T et al. European Journal of Clinical Chemistry . 1991

[8] Westra P et al. British Journal of Anaesthesia . 1986

[9] Thomsen T et al. Biochemical Pharmacology . 1991

[10] Pharmacology[C]. 2002年中日毒理学和药理学联合研讨会,2002

[1] Thomsen T et al. Life Sciences . 1990

[2] Bickel U et al. Neuropharmacology . 1991

[3] Pharmacology[C]. 2002年中日毒理学和药理学联合研讨会,2002

[4] Sweeney J E et al. Psychopharmacology . 1990

[5] Sweeney J E et al. Pharmacol Biochem Behav . 1989

[6] Thomsen T et al. European Journal of Clinical Pharmacology .

[7] Thomsen T et al. European Journal of Clinical Chemistry . 1991

[8] Westra P et al. British Journal of Anaesthesia . 1986

[9] Thomsen T et al. Biochemical Pharmacology . 1991

[10] Pharmacology[C]. 2002年中日毒理学和药理学联合研讨会,2002